MENTOR: Rituximab (vs Cyclosporine) for Membranous GN ca. 2019 from @NEJM
📌 Non-inferior in inducing complete/ partial remission of proteinuria at 12 months
#Nephpearls #NephJC
👉🏼 nejm.org/doi/pdf/10.105…
Membranous Nephropathy: Diagnosis and Treatment
#KDIGOConnections from Dr David Bourne @arkanalabs #Nephpearls #NephJC
Membranous Nephropathy: Antibody guided diagnostic and treatment algorithm ca. 2017 #Nephpearls #NephJC
👉🏼 cjasn.asnjournals.org/content/clinja…
Membranous Nephropathy: Proposed categorization ca. 2019 from @goKDIGO @Kidney_Int
#Nephpearls #NephJC
👉🏼 kdigo.org/wp-content/upl…
Membranous Nephropathy: This schematic presents a categorization of primary MN into subgroups on the basis of association with the two known antigens, PLA2R and THSD7A ca. 2017 from @JASN_News
#Nephpearls #NephJC
👉🏼 jasn.asnjournals.org/content/jnephr…
Membranous Nephropathy: Treatment regimens PRE-MENTOR #Nephpearls #NephJC
Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy ca. 1984 from @NEJM
#VisualAbstract by @CristhianMuM
#Nephpearls #NephJC
👉🏼 nejm.org/doi/10.1056/NE…
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy ca. 2019
#Nephpearls #NephJC
#VisualAbstract by @CristhianMuM
👉🏼 nejm.org/doi/pdf/10.105…
GEMRITUX: Rituximab for Severe Membranous Nephropathy ca. 2017 from @JASN_News
#VisualAbstract by @CristhianMuM
#Nephpearls #NephJC
👉🏼 jasn.asnjournals.org/content/jnephr…
Membranous Nephropathy: Discovery of PLA2R and THSD7A has led to a paradigm shift in diagnosis, monitoring, and classification of patients #Nephpearls #NephJC
👉🏼 openaccessgovernment.org/precision-medi…
Summary of the most common IST protocols for treating patients with primary membranous nephropathy ca. 2017 from @CJASN #Nephpearls
👉🏼 cjasn.asnjournals.org/content/clinja…
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.